Reaction Details Report a problem with these data
Target
Fibroblast growth factor receptor 4 [460-802]
Ligand
BDBM436200
Substrate
n/a
Meas. Tech.
Inhibition Assay
IC50
<10±n/a nM
Citation
 Kong, NX; Zhou, C; Zheng, Z Heterocyclic compounds used as FGFR inhibitors US Patent  US10590109 Publication Date 3/17/2020 
Target
Name:
Fibroblast growth factor receptor 4 [460-802]
Synonyms:
FGFR4 | FGFR4_HUMAN | Fibroblast growth factor receptor 4 (FGFR4)(aa 460-802) | JTK2 | TKF
Type:
Enzyme Catalytic Domain
Mol. Mass.:
37991.56
Organism:
Homo sapiens (Human)
Description:
aa 460-802
Residue:
343
Sequence:
WEFPRDRLVLGKPLGEGCFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGPDLSPDGPRSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSEEYLDLRLTFGPYSPSGGDASSTCSSSDSVFSHDPLPLGSSSFPFGSGVQT
  
Inhibitor
Name:
BDBM436200
Synonyms:
US10590109, Compound 18 | US10590109, Compound 25
Type:
Small organic molecule
Emp. Form.:
C24H29N7O5
Mol. Mass.:
495.531
SMILES:
COC[C@@H](C)Oc1cc(NC(=O)N(C)c2ccc(CN3CCN(C)CC3=O)c(C=O)n2)ncc1C#N |r|
Structure:
Search PDB for entries with ligand similarity: